Target (CBDY) Gains from Investment Securities (2021 - 2023)
Target (CBDY) reported Gains from Investment Securities of $1343.0 for Q4 2023, down 99.4% year-over-year from $225075.0 in Q4 2022, and up 100.17% quarter-over-quarter from -$781152.0 in Q3 2023.
Target (CBDY) Gains from Investment Securities (2021 - 2023) Analysis & Trends
Target (CBDY) has 3 years of Gains from Investment Securities data on file, last reported at $1343.0 in Q4 2023.
- Gains from Investment Securities for Q4 2023 came in at $1343.0, down 99.4% year-over-year; the trailing twelve-month figure through Dec 2023 was -$439018.0 (up 56.76% YoY), and the FY2023 annual result was -$439018.0, up 56.76% from the prior year.
- Gains from Investment Securities grew to $1343.0 in Q4 2023 per CBDY's latest filing, from -$781152.0 in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $813954.0 in Q2 2021 and troughed at -$1.2 million in Q3 2022.
- A 3-year average of -$53479.8 and a median of $53481.5 in 2021 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2022 and 2023: Gains from Investment Securities sank 1274.43% in 2022, then soared 290.51% in 2023.
- A 3-year view of Gains from Investment Securities shows it stood at $105620.0 in 2021, then jumped by 113.1% to $225075.0 in 2022, then plunged by 99.4% to $1343.0 in 2023.
- Business Quant data shows CBDY's Gains from Investment Securities at $1343.0 in Q4 2023, -$781152.0 in Q3 2023, and -$198120.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Target | - | - | 191,787.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 1,343.00 |
| Dec 31, 2023 | 1,343.00 |
| Sep 30, 2023 | -781,152.00 |
| Sep 30, 2023 | -781,152.00 |
| Jun 30, 2023 | -198,120.00 |
| Jun 30, 2023 | -198,120.00 |
| Mar 31, 2023 | 538,911.00 |
| Mar 31, 2023 | 538,911.00 |
| Dec 31, 2022 | 225,075.00 |
| Dec 31, 2022 | 225,075.00 |
| Sep 30, 2022 | -1.24 Mn |
| Sep 30, 2022 | -1.24 Mn |
| Jun 30, 2022 | -138,002.00 |
| Jun 30, 2022 | -138,002.00 |
| Mar 31, 2022 | 138,002.00 |
| Mar 31, 2022 | 138,002.00 |
| Sep 30, 2021 | 105,620.00 |
| Sep 30, 2021 | 105,620.00 |
| Jun 30, 2021 | 813,954.00 |
| Jun 30, 2021 | 813,954.00 |